[SCHEDULE 13G] Enveric Biosciences, Inc. SEC Filing

Rhea-AI Filing Summary

AdvisorShares Trust reported beneficial ownership of 203,679 shares of Enveric Biosciences, Inc. (ENVB), representing 6.27% of the outstanding common stock as of the 09/30/2025 event date. The filing is a Schedule 13G, indicating passive investment: the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control. The filing lists Stefanie Little, Chief Compliance Officer, as the signatory for AdvisorShares Trust and shows the trust is organized in Delaware. The reporting person has sole voting and sole dispositive power over the reported shares and reports no shared powers.

Positive

• 6.27% stake reported, a clearly disclosed, material passive holding
• Sole voting and dispositive power over 203,679 shares provides clarity on control of the position
• Filed on Schedule 13G, indicating the position is held in the ordinary course and not to influence control

Negative

• None.

Insights

Portfolio Analyst

AdvisorShares Trust holds a material passive stake of 6.27% in ENVB.

AdvisorShares Trust reports 203,679 shares, giving it 6.27% of Enveric Biosciences common stock as of 09/30/2025. The Schedule 13G classification and the certification language state the position is held in the ordinary course and not intended to influence control.

The filing shows sole voting and sole dispositive power for the reporting person, which means AdvisorShares Trust can vote and sell these shares independently. No shared ownership or group affiliation is reported.

SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

SCHEDULE 13G

UNDER THE SECURITIES EXCHANGE ACT OF 1934

Enveric Biosciences, Inc.

(Name of Issuer)

Common Stock, $0.01 par value

(Title of Class of Securities)

29405E208

(CUSIP Number)

09/30/2025

(Date of Event Which Requires Filing of this Statement)

Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

Rule 13d-1(b)

Rule 13d-1(c)

Rule 13d-1(d)

SCHEDULE 13G

CUSIP No. 29405E208

1

Names of Reporting Persons

AdvisorShares Trust

2

Check the appropriate box if a member of a Group (see instructions)

(a)
(b)

3

Sec Use Only

4

Citizenship or Place of Organization

DELAWARE

Number of Shares Beneficially Owned by Each Reporting Person With:

5	Sole Voting Power 203,679.00
6	Shared Voting Power 0.00
7	Sole Dispositive Power 203,679.00
8	Shared Dispositive Power 0.00

9

Aggregate Amount Beneficially Owned by Each Reporting Person

203,679.00

10

Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)

11

Percent of class represented by amount in row (9)

6.27 %

12

Type of Reporting Person (See Instructions)

IV

SCHEDULE 13G

Item 1.
(a)	Name of issuer: Enveric Biosciences, Inc.
(b)	Address of issuer's principal executive offices: 4851 Tamiami Trail N, Suite 200, Naples, Florida, 34103
Item 2.
(a)	Name of person filing: AdvisorShares Trust
(b)	Address or principal business office or, if none, residence: 4800 Montgomery Lane, Suite 150 Bethesda, Maryland 20814
(c)	Citizenship: Delaware
(d)	Title of class of securities: Common Stock, $0.01 par value
(e)	CUSIP No.: 29405E208
Item 3.	If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)	Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)	Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)	Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)	Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)	An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)	An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)	A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)	A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)	A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)	A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J), please specify the type of institution:
(k)	Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.	Ownership
(a)	Amount beneficially owned: 203,679
(b)	Percent of class: 6.27 %
(c)	Number of shares as to which the person has:
	(i) Sole power to vote or to direct the vote: 203,679
	(ii) Shared power to vote or to direct the vote: 0
	(iii) Sole power to dispose or to direct the disposition of: 203,679
	(iv) Shared power to dispose or to direct the disposition of: 0
Item 5.	Ownership of 5 Percent or Less of a Class.
Item 6.	Ownership of more than 5 Percent on Behalf of Another Person.
	Not Applicable
Item 7.	Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
	Not Applicable
Item 8.	Identification and Classification of Members of the Group.
	Not Applicable
Item 9.	Notice of Dissolution of Group.
	Not Applicable

Item 10.

Certifications:

By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under ?? 240.14a-11.

SIGNATURE

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

AdvisorShares Trust

Signature:	/s/ Stefanie Little
Name/Title:	Stefanie Little - Chief Compliance Officer
Date:	10/03/2025

FAQ

What stake does AdvisorShares Trust hold in Enveric Biosciences (ENVB)?

AdvisorShares Trust beneficially owns 203,679 shares, representing 6.27% of ENVB common stock as of 09/30/2025.

Is the AdvisorShares Trust position in ENVB active or passive?

The filing is a Schedule 13G and includes a certification that the securities are held in the ordinary course of business and not for the purpose of changing or influencing control, indicating a passive position.

Does AdvisorShares Trust share voting or dispositive power over the ENVB shares?

No. The filing reports sole voting power and sole dispositive power for all 203,679 shares and 0 shared powers.

Who signed the Schedule 13G for AdvisorShares Trust?

The document is signed by Stefanie Little, Chief Compliance Officer, on behalf of AdvisorShares Trust, dated 10/03/2025.

Where is AdvisorShares Trust organized?

The filing lists AdvisorShares Trust as a Delaware organization (Citizenship: Delaware in the filing).